GlassScriptPhysician profile
Lisa Maselli
NPI 1346212834
$2,809.92
in general payments reported to CMS, 2019-2025
30 companies · $436 in 2025
The $436 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $252 · 2021: $630 · 2022: $658 · 2023: $286 · 2024: $312 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,033.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.95 | 2019-2023 | |
| Optumhealth Care Solutions, LLC | $508.19 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Hologic Sales and Service, LLC | $180.14 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Amgen INC. | $155.18 | 2021-2024 | Evenity, Prolia |
| Daiichi Sankyo INC. | $139.20 | 2019-2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $121.94 | 2020-2024 | |
| Organon LLC | $116.49 | 2021-2024 | Nexplanon |
| Therapeuticsmd, INC. | $109.85 | 2020-2022 | |
| Scynexis, INC. | $103.60 | 2021-2022 | |
| Pfizer INC. | $83.38 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $78.43 | 2021-2022 | |
| Astellas Pharma US INC | $55.64 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $46.04 | 2019-2021 | |
| Urovant Sciences INC | $43.66 | 2021-2022 | |
| Exact Sciences Corporation | $39.51 | 2025 | Cologuard Collection Kit |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $36.05 | 2023 | |
| Avion Pharmaceuticals | $29.89 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $27.34 | 2025 | Gemtesa |
| Shield Therapeutics INC | $24.07 | 2022 | |
| Solventum Corporation | $21.08 | 2025 | Prevena, V.A.C.Ulta |
| Avanos Medical | $19.26 | 2024 | On-Q* Pump and Accessories |
| Exeltis, USA INC. | $18.73 | 2022 | |
| Evofem Biosciences, INC. | $17.04 | 2022 | |
| Novo Nordisk INC | $16.06 | 2023 | |
| Amag Pharmaceuticals, INC. | $15.06 | 2019 | |
| Duchesnay USA Incorporated | $13.38 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.90 | 2021 | |
| Channel Medsystems, INC. | $11.87 | 2022 | |
| Millicent US INC | $11.70 | 2019 | |
| Minerva Surgical, INC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Maselli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.